Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
AVXL
#3534
Anavex Life Sciences Corp. - Common Stock
2.5
0
USD
+0.03%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+2.88%
Monthly Change
-3.85%
6 month change
-48.67%
Year Change
-77.68%
Previous Close
2.4
3
Open
2.5
0
Low
2.5
0
High
2.5
0
Volume
34
Markets
US Stock Market
Healthcare
Biotechnology
AVXL
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
TTM
Cash from operating activities
-12.12 M
-5.86 M
-12.46 M
-8.6 M
-7.15 M
-34.08 M
Cash from investing activities
—
—
—
—
-4.66 M
—
Cash from financing activities
708 K
852 K
-2.14 M
10.02 M
36.32 M
45.05 M
Free cash flow
-12.12 M
-5.86 M
-12.46 M
-8.6 M
-7.15 M
-34.08 M
News
Anavex: Waiting On Validation As Blarcamesine Shows Some Promise (NASDAQ:AVXL)
Amyloid Setback: Future Possibilities For The Treatment Of Alzheimer's Disease
Is AC Immune (ACIU) Outperforming Other Medical Stocks This Year?
Anavex reports positive preclinical Parkinson’s study results
What's Going On With Anavex Life Sciences Stock On Wednesday? - Anavex Life Sciences (NASDAQ:AVXL)
Anavex Life Sciences at TD Cowen Conference: Promising Alzheimer’s Drug Results
Is Alcon (ALC) Stock Outpacing Its Medical Peers This Year?
Anavex Life Sciences appoints Dr. Axel Paeger to board
Anavex Life Sciences (AVXL) Upgraded to Buy: Here's What You Should Know
Is Anavex Life Sciences (AVXL) Stock Outpacing Its Medical Peers This Year?
Anavex: Negative EU Opinion Leaves Blarcamesine In Regulatory Purgatory (NASDAQ:AVXL)
Earnings call transcript: Anavex Life Sciences beats EPS forecast in Q1 2026